CYP2C9andABCG2polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case–control study

2013 ◽  
Vol 14 (12) ◽  
pp. 1419-1431 ◽  
Author(s):  
Nikica Miroševic Skvrce ◽  
Nada Božina ◽  
Lada Zibar ◽  
Ivan Barišic ◽  
Lana Pejnovic ◽  
...  
Keyword(s):  
Risk Factors ◽  
Renal Transplant ◽  
Adverse Drug Reactions ◽  
Case Control Study ◽  
Case Control ◽  
Drug Reactions ◽  
Transplant Patients ◽  
Renal Transplant Patients ◽  
Control Study

scholarly journals Cutaneous adverse drug reactions to psychotropic drugs and their risk factors – a case-control study

2019 ◽  
Vol 29 (1) ◽  
pp. 111-121 ◽  
Author(s):  
Waldemar Greil ◽  
Xueqiong Zhang ◽  
Hans Stassen ◽  
Renate Grohmann ◽  
René Bridler ◽  
...  
Keyword(s):  
Risk Factors ◽  
Adverse Drug Reactions ◽  
Psychotropic Drugs ◽  
Case Control Study ◽  
Case Control ◽  
Drug Reactions ◽  
Control Study

Risk Factors for Nosocomial Urinary Tract and Postoperative Wound Infections in Renal Transplant Patients: A Matched-Pair Case-Control Study

1992 ◽  
Vol 147 (4) ◽  
pp. 994-998 ◽  
Author(s):  
Milton S. Lapchik ◽  
Adauto Castelo Filho ◽  
José Osmar A. Pestana ◽  
Álvaro P. Silva Filho ◽  
Sérgio B. Wey
Keyword(s):  
Risk Factors ◽  
Urinary Tract ◽  
Renal Transplant ◽  
Case Control Study ◽  
Case Control ◽  
Matched Pair ◽  
Wound Infections ◽  
Postoperative Wound ◽  
Transplant Patients ◽  
Control Study

Relationship Between Vitamin D Blood Levels and Cancer Development in Renal Transplant Patients: A Case-Control Study

2016 ◽  
Vol 48 (9) ◽  
pp. 2959-2961 ◽  
Author(s):  
J. Ugalde-Altamirano ◽  
D. Álvarez Villegas ◽  
I. Revuelta ◽  
A. Coloma ◽  
J.-V. Torregrosa
Keyword(s):  
Vitamin D ◽  
Renal Transplant ◽  
Case Control Study ◽  
Case Control ◽  
Cancer Development ◽  
Blood Levels ◽  
Transplant Patients ◽  
Renal Transplant Patients ◽  
Control Study

scholarly journals Cytomegalovirus Viremia and Risk Factors in Renal Transplant Recipients in Iran: a Prospective Case-control Study

2021 ◽  
Author(s):  
Najmeh Parhizgari ◽  
Farhad Rezaei ◽  
Mohamad-Reza Khatami ◽  
Sayed Mahdi Marashi ◽  
Mohammad Farahmand ◽  
...  
Keyword(s):  
Renal Transplant ◽  
Kidney Transplant ◽  
Case Control Study ◽  
Case Control ◽  
Control Group ◽  
Transplant Recipients ◽  
Transplant Patients ◽  
Kidney Transplant Patients ◽  
Control Study ◽  
Prospective Case Control Study

Abstract Background: In spite of effective anti-viral drugs and risk-balanced prophylaxis regimen, cytomegalovirus (CMV) remains a major reason of morbidity in kidney transplant patients. The aim of present study was to evaluate CMV viral load and laboratory findings correlation with CMV viremia graft origin and investigation on late or early onset CMV infection in kidney transplant recipients with CMV viremia. Methods: This research designed as a prospective case-control study based on CMV PCR test and exclusion of other viral infection among renal transplant patients in Iran.Results: From 192 examined patients, 153 participants were qualified to enter the study: 43 in case (with CMV viremia) and 110 in control group (CMV negative test). Statistical analysis performed to identify the risk factors raising this viral viremia among kidney transplant patients. Conclusion: Receiving a renal graft from a deceased donor significantly raise the chance of viremia in renal transplant patients. The median month of CMV viremia occurrence was month 4 after transplantation in both groups. Serum laboratory testing showed creatinine and platelets significantly raised and reduced, retrospectively in the case compare to control group. Our results indicating the viremia has not affected the survival of the allograft or patient.

Sign in / Sign up

Export Citation Format

Share Document